查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790235

感染控制市場規模、佔有率和趨勢分析報告：按類型、最終用途、地區和細分市場預測，2025 年至 2030 年

Infection Control Market Size, Share & Trends Analysis Report By Type, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

感染控制市場概況

2024 年全球感染控制市場價值估計為 523.8 億美元，預計到 2030 年將達到 742.1 億美元，2025 年至 2030 年期間的複合年成長率為 6.1%。該市場主要受需要預防感染的外科手術和臨床程序增加的推動。

感染控制技術的進步顯著提高了醫療機構的感染預防和控制能力。自動消毒系統、紫外線技術、抗菌表面塗層和先進的空氣過濾系統等創新技術已被證明可有效降低高達 30% 的醫院感染 (HAI)，預計將促進市場成長。滅菌服務外包的增加以及先進滅菌解決方案的採用進一步促進了感染控制市場的成長。關鍵成長要素之一是政府加強實施先進的感染預防措施。政府機構擴大參與發布指南，以提高全球意識並採取有效的預防措施，預計這些措施將在整個預測期內促進市場成長。例如，世界衛生組織 (WHO) 發布了醫療保健領域流行病和流行性急性呼吸道疾病預防控制指南。這些指南涵蓋了從手部衛生和個人防護工具使用等標準預防措施到消毒和滅菌指南。

根據美國國家醫學圖書館2024年5月發表的一篇論文，急性呼吸道感染疾病（ARI）是全球重大的健康負擔，每年造成約425萬人死亡。這些感染疾病每年導致數百萬人次門診就診，尤其影響老年人、幼兒以及氣喘和心臟病等慢性疾病患者等高風險族群。

肺炎等感染疾病以及血流感染、尿道感染、手術部位感染和 MRSA 等感染佔院內感染的大多數。其他主要的醫院相關感染疾病(HAI) 包括導管相關尿道感染、人工呼吸器相關性肺炎和導管相關血流感染疾病。 HAI 嚴重影響全球死亡率，因為它們影響患者的康復。根據 2023 年 4 月 NIH 的一篇報導，HAI 是醫院中最常見的不良事件，導致嚴重的健康風險、發病率和死亡率增加，並增加患者、家庭和醫療保健系統的成本。 HAI 影響美國約 3.2% 的住院患者和歐盟 6.5% 的住院患者，預計全球盛行率將持續上升。這導致對有效的感染預防和控制解決方案的需求增加。

根據世界衛生組織《醫院內獲得性感染預防實用指南》，手術感染疾病導致的住院時間增加約8天。預計住院時間的延長將顯著增加住院期間的總費用，從而增加了採取感染預防措施的臨床緊迫性。由於過度使用資源來治療獲得性感染疾病，延長住院時間對醫院和醫療保健支付者來說也是不經濟的。這些額外費用主要來自藥物使用量的增加、額外的診斷檢測和實驗室設備的增加，造成資源分配的不平衡。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章感染控制市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 感染控制市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
  • 感染控制市場：通路分析

第4章感染控制市場：按類型估計和趨勢分析

  • 類型細分儀表板
  • 感染控制市場：類型變化分析
  • 全球感染控制市場規模及趨勢分析（按類型）（2018-2030）
  • 裝置
    • 消毒劑
    • 消毒器
    • 其他
  • 服務
    • 合約節育手術
    • 傳染性廢棄物的處理
  • 耗材
    • 傳染性廢棄物的處理
    • 消毒劑
    • 無菌耗材
    • 個人防護設備
    • 其他

第5章感染控制市場：依最終用途的估計和趨勢分析

  • 最終用途細分儀表板
  • 感染控制市場：最終用途變異分析
  • 全球感染控制市場規模與趨勢分析（依最終用途，2018-2030 年）
  • 醫院
  • 醫療設備公司
  • 臨床實驗室
  • 製藥實驗室
  • 其他

第6章感染控制市場：按地區估計和趨勢分析

  • 區域市場儀表板
  • 2024 年及 2030 年區域市場佔有率分析
  • 感染控制市場（按地區）: 關鍵要點
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • 3M
    • Belimed AG
    • O& M Halyard or its affiliates.
    • GETINGE AB（publ）Corporate
    • ASP
    • MATACHANA
    • Sterigenics US, LLC-A Sotera Health company
    • MMM Group
    • Medivators Inc.
    • STERIS.
    • Midmark Corporation
    • W& H
Product Code: GVR-1-68038-822-0

Infection Control Market Summary

The global infection control market size was estimated at USD 52.38 billion in 2024, and is projected to reach USD 74.21 billion by 2030, growing at a CAGR of 6.1% from 2025 to 2030. The market is primarily driven by an increasing number of surgical & clinical procedures that require infection prevention.

Technological advancements in infection control have significantly enhanced the ability of healthcare providers to prevent and manage infections. Innovations such as automated disinfection systems, UV light technology, antimicrobial surface coatings, and advanced air filtration systems have demonstrated efficacy in reducing HAIs by up to 30% and is expected to contribute to the market growth. An increase in outsourcing sterilization services and the introduction of advanced sterilizing solutions are further contributing to the growth of the market for infection control. One of the important growth drivers is the increasing number of government initiatives to ensure highly intensive infection prevention. Government organizations are increasingly involved in issuing guidelines to promote awareness and efficient prevention measures globally, which is expected to contribute to market growth throughout the forecast period. For instance, the World Health Organization (WHO) has issued guidelines for preventing and controlling pandemic- and epidemic-prone acute respiratory diseases in healthcare. The guidelines range from standard precautions such as hand hygiene and usage of personal protective equipment to guidelines for disinfection and sterilization.

According to the article published by the National Library of Medicine in May 2024, Acute respiratory infections (ARIs) are a major global health burden, leading to around 4.25 million deaths annually. These infections lead to millions of outpatient visits each year, particularly affecting high-risk groups such as the elderly, young children, and individuals with chronic conditions such as asthma or heart disease.

Diseases such as pneumonia and infections such as bloodstream, urinary tract, surgical site, and MRSA constitute most hospital-acquired infections. Other major healthcare-associated infections (HAIs) include catheter-associated urinary tract infections, ventilator-associated pneumonia, and catheter-related bloodstream. One of the utmost concerns for the market is HAIs, which affect patient recovery; thereby, mortality rates are being significantly impacted globally. According to an article by NIH in April 2023, HAIs are the most common adverse effects in hospitals, leading to serious health risks, increased morbidity and mortality, and higher costs for patients, families, and healthcare systems. HAIs affect about 3.2% of hospitalized patients in the U.S. and 6.5% in the EU, with global prevalence expected to be even higher. This facilitates the need for effective infection prevention and control solutions.

According to a practical guide published by the WHO on preventing hospital-acquired infections, the increase in hospitalization duration with surgical infections was approximately eight days. These prolonged stays are predicted to significantly contribute to the overall costs incurred during the hospitalization period, thus, raising the clinical urgency for adopting infection prevention measures. It is presumed that prolonged hospital stay is also not economical for the hospitals and healthcare payers due to excessive usage of resources to treat the acquired infection. These additional costs are majorly generated through increased usage of drugs, additional diagnostic studies, and laboratory equipment, creating a resource allocation imbalance.

Global Infection Control Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented the global infection control market on the basis of type, end use, and region:

  • Type Outlook (Revenue, USD Billion, 2018 - 2030)
  • Equipment
    • Disinfectors
    • Washers
    • Flushes
    • Endoscope Reprocessors
    • Sterilization Equipment
    • Heat Sterilization Equipment
    • Low Temperature Sterilization Equipment
    • Radiation Sterilization Equipment
    • Filtration Sterilization Equipment
    • Liquid Sterilization Equipment
    • Others
  • Services
    • Contract Sterilization
    • Ethylene Oxide Sterilization
    • E-beam Sterilization
    • Gamma Sterilization
    • Others
    • Infectious Waste Disposal
  • Consumables
    • Infectious Waste Disposal
    • Disinfectants
    • Sterilization Consumables
    • Safety enhanced medical devices
    • Personal Protective Equipment
    • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Laboratories
  • Others
  • Regional Outlook (Revenue, USD Billion, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Infection Control Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Infection Control Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Infection Control Market: Pipeline Analysis

Chapter 4. Infection Control Market: Type Estimates & Trend Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Infection Control Market: Type Movement Analysis
  • 4.3. Global Infection Control Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Equipment
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Disinfectors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.2. Washers
        • 4.4.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.3. Flushes
        • 4.4.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.2.4. Endoscope Reprocessors
        • 4.4.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Sterilization Equipment
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.2. Heat sterilization equipment
        • 4.4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.3. Low Temperature Sterilization Equipment
        • 4.4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.4. Radiation Sterilization Equipment
        • 4.4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.5. Filtration Sterilization Equipment
        • 4.4.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.3.6. Liquid Sterilization Equipment
        • 4.4.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Contract Sterilization
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.2. Ethylene Oxide Sterilization
        • 4.5.2.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.3. E-beam Sterilization
        • 4.5.2.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.4. Gamma Sterilization
        • 4.5.2.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.5.2.5. Others
        • 4.5.2.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Infectious Waste Disposal
  • 4.6. Consumables
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Infectious Waste Disposal
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Disinfectants
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Sterilization Consumables
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.5. Personal Protective Equipment
      • 4.6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Infection Control Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Infection Control Market: End Use Movement Analysis
  • 5.3. Global Infection Control Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Medical Device Companies
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Clinical Laboratories
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Pharmaceutical Laboratories
    • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Infection Control Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. Infection Control Market by Region: Key Takeaways
  • 6.4. North America
    • 6.4.1. U.S.
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Canada
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Mexico
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. UK
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Germany
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. France
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Italy
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Spain
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Norway
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Sweden
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Japan
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. China
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. India
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Australia
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Thailand
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Brazil
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Argentina
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. South Africa
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Saudi Arabia
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. UAE
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.4. Kuwait
      • 6.8.4.1. Key country dynamics
      • 6.8.4.2. Regulatory framework/ reimbursement structure
      • 6.8.4.3. Competitive scenario
      • 6.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. 3M
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Belimed AG
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. O&M Halyard or its affiliates.
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. GETINGE AB (publ) Corporate
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. ASP
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. MATACHANA
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Sterigenics U.S., LLC - A Sotera Health company
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. MMM Group
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Medivators Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. STERIS.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Midmark Corporation.
      • 7.4.11.1. Company overview
      • 7.4.11.2. Financial performance
      • 7.4.11.3. Product benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. W&H
      • 7.4.12.1. Company overview
      • 7.4.12.2. Financial performance
      • 7.4.12.3. Product benchmarking
      • 7.4.12.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global infection control market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global infection control market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America infection control market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America infection control market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. infection control market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada infection control market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico infection control market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe infection control market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe infection control market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany infection control market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK infection control market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 21 France infection control market, by type, 2018 - 2030 (USD Million)
  • Table 22 France infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Italy infection control market, by type, 2018 - 2030 (USD Million)
  • Table 24 Italy infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Spain infection control market, by type, 2018 - 2030 (USD Million)
  • Table 26 Spain infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark infection control market, by type, 2018 - 2030 (USD Million)
  • Table 28 Denmark infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Sweden infection control market, by type, 2018 - 2030 (USD Million)
  • Table 30 Sweden infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Norway infection control market, by type, 2018 - 2030 (USD Million)
  • Table 32 Norway infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific infection control market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific infection control market, by type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China infection control market, by type, 2018 - 2030 (USD Million)
  • Table 37 China infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan infection control market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 40 India infection control market, by type, 2018 - 2030 (USD Million)
  • Table 41 India infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea infection control market, by type, 2018 - 2030 (USD Million)
  • Table 43 Australia infection control market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand infection control market, by type, 2018 - 2030 (USD Million)
  • Table 45 Thailand infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America infection control market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America infection control market, by type, 2018 - 2030 (USD Million)
  • Table 48 Latin America infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil infection control market, by type, 2018 - 2030 (USD Million)
  • Table 50 Brazil infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina infection control market, by type, 2018 - 2030 (USD Million)
  • Table 52 Argentina infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 53 MEA infection control market, by country, 2018 - 2030 (USD Million)
  • Table 54 MEA infection control market, by type, 2018 - 2030 (USD Million)
  • Table 55 MEA infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa infection control market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia infection control market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE infection control market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE infection control market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait infection control market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait infection control market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Infection control market: market outlook
  • Fig. 10 Infection control market competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Infection control market driver impact
  • Fig. 16 Infection control market restraint impact
  • Fig. 17 Infection control market strategic initiatives analysis
  • Fig. 18 Infection control market: Type movement analysis
  • Fig. 19 Infection control market: Type outlook and key takeaways
  • Fig. 20 Equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Disinfectors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Washers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Flushes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Endoscope reprocessors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Heat sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Low temperature sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Radiation sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Filtration sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Liquid sterilization equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Contract sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Ethylene oxide Sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 E-beam sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Gamma sterilization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Infectious waste Disposal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Infectious waste disposal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Disinfectants market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Safety enhanced medical devices market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Sterilization consumables market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Personal protective equipment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 45 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 46 Infection control market: End use movement Analysis
  • Fig. 47 Infection control market: End use outlook and key takeaways
  • Fig. 48 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Medical device companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Clinical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Pharmaceutical laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Global infection control market: Regional movement analysis
  • Fig. 54 Global infection control market: Regional outlook and key takeaways
  • Fig. 55 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)